DS
AVNS

David Shaw’s Avanos Medical AVNS Stock Holding History

David Shaw’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-50,000
Closed -$1.63M – 3364
2016
Q2 		$1.63M Sell
50,000
-50,000
-50% -$1.53M ﹤0.01% 2084
2016
Q1 		$2.87M Buy
100,000
+88,276
+753% +$2.35M 0.01% 1628
2015
Q4 		$392K Hold
11,724
– – ﹤0.01% 3224
2015
Q3 		$333K Hold
11,724
– – ﹤0.01% 3302
2015
Q2 		$475K Hold
11,724
– – ﹤0.01% 3186
2015
Q1 		$577K Sell
11,724
-27,696
-70% -$1.28M ﹤0.01% 2963
2014
Q4 		$1.79M Buy
+39,420
New +$1.55M ﹤0.01% 2359

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

David Shaw's AVNS Position: Q2 2026 in Review

David Shaw reduced its Avanos Medical (AVNS) stake by 58% in Q2 2026, selling an estimated $9.15M and leaving 280,729 shares worth $6.98M. The position accounts for ﹤0.01% of the portfolio, ranked #2144.

David Shaw first reported a position in AVNS in Q4 2014 and has held it in 47 quarters since. The position peaked at $30.1M in Q1 2022. 284 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • David Shaw held 280,729 shares of Avanos Medical worth $6.98M as of Q2 2026.
  • David Shaw sold 390,684 Avanos Medical shares in Q2 2026, an estimated $9.15M.
  • Avanos Medical made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2144 holding.
  • David Shaw first reported a position in Avanos Medical in Q4 2014 and has held it in 47 quarters since.
  • David Shaw's Avanos Medical position peaked at $30.1M in Q1 2022.
  • 284 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.